These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21590355)

  • 1. Effects of stable knockdown of Aurora kinase A on proliferation, migration, chromosomal instability, and expression of focal adhesion kinase and matrix metalloproteinase-2 in HEp-2 cells.
    Zhang H; Chen X; Liu B; Zhou L
    Mol Cell Biochem; 2011 Nov; 357(1-2):95-106. PubMed ID: 21590355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Suppression of Aurora-A by RNA interference inhibits laryngeal cancer Hep-2 cell growth].
    Zhang H; Chen XH; Cai CP; Wang SL; Liu BY; Zhou L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jan; 47(1):58-63. PubMed ID: 22455777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Aurora-A promotes laryngeal cancer progression by enhancing invasive ability and chromosomal instability.
    Zhang H; Chen X; Jin Y; Liu B; Zhou L
    Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):607-14. PubMed ID: 21584819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the FAK/PI3K pathway is crucial for AURKA-induced epithelial-mesenchymal transition in laryngeal cancer.
    Yang L; Zhou Q; Chen X; Su L; Liu B; Zhang H
    Oncol Rep; 2016 Aug; 36(2):819-26. PubMed ID: 27373675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation.
    Yang LY; He CY; Chen XH; Su LP; Liu BY; Zhang H
    Oncotarget; 2016 Jul; 7(30):48346-48359. PubMed ID: 27356739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.
    Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H
    Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Aurora-A enhances invasion and matrix metalloproteinase-2 expression in esophageal squamous cell carcinoma cells.
    Wang X; Lu N; Niu B; Chen X; Xie J; Cheng N
    Mol Cancer Res; 2012 May; 10(5):588-96. PubMed ID: 22522455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of Aurora kinase A by RNA interference inhibits tumor growth in human osteosarcoma cells by inducing apoptosis and G2/M cell cycle arrest.
    Jiang Z; Jiang J; Yang H; Ge Z; Wang Q; Zhang L; Wu C; Wang J
    Oncol Rep; 2014 Mar; 31(3):1249-54. PubMed ID: 24452445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.
    Dos Santos EO; Carneiro-Lobo TC; Aoki MN; Levantini E; Bassères DS
    Mol Cancer; 2016 Feb; 15():12. PubMed ID: 26842935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Down-regulation of histone deacetylase 2 induces cell apoptosis and inhibits cell proliferation and migration of laryngeal squamous cell carcinoma cells].
    Yuan LL; Lou WH; Sang JZ; Li SL; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):396-9. PubMed ID: 22932408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of long non-coding RNA SNHG1 contributes to proliferation and metastasis in laryngeal squamous cell carcinoma.
    Lin SX; Jiang H; Xiang GZ; Zhang WR; Weng YH; Qiu FD; Wu J; Wang HG
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1333-1341. PubMed ID: 29565491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma.
    Mazumdar A; Henderson YC; El-Naggar AK; Sen S; Clayman GL
    Head Neck; 2009 May; 31(5):625-34. PubMed ID: 19107951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion.
    Do TV; Xiao F; Bickel LE; Klein-Szanto AJ; Pathak HB; Hua X; Howe C; O'Brien SW; Maglaty M; Ecsedy JA; Litwin S; Golemis EA; Schilder RJ; Godwin AK; Connolly DC
    Oncogene; 2014 Jan; 33(5):539-49. PubMed ID: 23334327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS.
    Dawei H; Honggang D; Qian W
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):83-90. PubMed ID: 30454901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aurora-A expression is independently associated with chromosomal instability in colorectal cancer.
    Baba Y; Nosho K; Shima K; Irahara N; Kure S; Toyoda S; Kirkner GJ; Goel A; Fuchs CS; Ogino S
    Neoplasia; 2009 May; 11(5):418-25. PubMed ID: 19412426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI3K/Akt/mTOR pathway.
    Yang N; Hui L; Wang Y; Yang H; Jiang X
    Oncol Rep; 2014 Jun; 31(6):2651-9. PubMed ID: 24700142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting aurora kinase A inhibits hypoxia-mediated neuroblastoma cell tumorigenesis.
    Romain CV; Paul P; Lee S; Qiao J; Chung DH
    Anticancer Res; 2014 May; 34(5):2269-74. PubMed ID: 24778030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aurora kinase A induces chemotherapy resistance through revival of dormant cells in laryngeal squamous cell carcinoma.
    Yang LY; Shan YM; Zhang Y; Zhou EH; Chen XP; Zhang H
    Head Neck; 2019 Jul; 41(7):2239-2248. PubMed ID: 30706572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of AURKA Gene Expression Knockdown on Angiogenesis and Tumorigenesis of Human Ovarian Cancer Cell Lines.
    Wang C; Yan Q; Hu M; Qin D; Feng Z
    Target Oncol; 2016 Dec; 11(6):771-781. PubMed ID: 27250762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation.
    Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
    J Transl Med; 2011 Jun; 9():100. PubMed ID: 21718475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.